PRA’s Early Development Service group conducts Phase I-IIa studies in our clinics in Europe and the U.S. with bioanalytical laboratories in close proximity to each, facilitating analysis of time-critical patient samples. Additionally, we operate our Unit on Demand model in Central and Eastern Europe for early phase patient studies.